Pinedo HM - Search Results

1

Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer.

Middelburg R, de Haas RR, Dekker H, Kerkhoven RM, Pohlmann PR, Fuentes-Alburo A, Mohar A, Pinedo HM, Lankelma J. Middelburg R, et al. Among authors: pinedo hm. Clin Cancer Res. 2005 Mar 1;11(5):1863-9. doi: 10.1158/1078-0432.CCR-04-1372. Clin Cancer Res. 2005. PMID: 15756011 Free article.

2

Simulation model of doxorubicin activity in islets of human breast cancer cells.

Lankelma J, Fernández Luque R, Dekker H, Pinedo HM. Lankelma J, et al. Among authors: pinedo hm. Biochim Biophys Acta. 2003 Aug 22;1622(3):169-78. doi: 10.1016/s0304-4165(03)00139-9. Biochim Biophys Acta. 2003. PMID: 12928113

3

Doxorubicin gradients in human breast cancer.

Lankelma J, Dekker H, Luque FR, Luykx S, Hoekman K, van der Valk P, van Diest PJ, Pinedo HM. Lankelma J, et al. Among authors: pinedo hm. Clin Cancer Res. 1999 Jul;5(7):1703-7. Clin Cancer Res. 1999. PMID: 10430072 Clinical Trial.

4

Unchanged pharmacokinetics of VP-16-213 (etoposide, NSC 141540) during concomitant administration of doxorubicin and cyclophosphamide.

van Hoogenhuijze J, Lankelma J, Stam J, Pinedo HM. van Hoogenhuijze J, et al. Among authors: pinedo hm. Eur J Cancer Clin Oncol. 1987 Jun;23(6):807-11. doi: 10.1016/0277-5379(87)90283-5. Eur J Cancer Clin Oncol. 1987. PMID: 2820744

5

A mathematical model of drug transport in human breast cancer.

Lankelma J, Fernández Luque R, Dekker H, Schinkel W, Pinedo HM. Lankelma J, et al. Among authors: pinedo hm. Microvasc Res. 2000 Jan;59(1):149-61. doi: 10.1006/mvre.1999.2218. Microvasc Res. 2000. PMID: 10625582

6

Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells.

Pinedo HM, Buter J, Luykx-de Bakker SA, Pohlmann PR, van Hensbergen Y, Heideman DA, van Diest PJ, de Gruijl TD, van der Wall E. Pinedo HM, et al. Eur J Cancer. 2003 May;39(8):1061-7. doi: 10.1016/s0959-8049(03)00131-x. Eur J Cancer. 2003. PMID: 12736104

7

Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.

Versantvoort CH, Broxterman HJ, Pinedo HM, de Vries EG, Feller N, Kuiper CM, Lankelma J. Versantvoort CH, et al. Among authors: pinedo hm. Cancer Res. 1992 Jan 1;52(1):17-23. Cancer Res. 1992. PMID: 1309222

8

Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system.

Spoelstra EC, Pinedo HM, Dekker H, Peters GJ, Lankelma J. Spoelstra EC, et al. Among authors: pinedo hm. Cancer Chemother Pharmacol. 1991;27(4):320-5. doi: 10.1007/BF00685119. Cancer Chemother Pharmacol. 1991. PMID: 1998989

9

The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells.

Cervantes A, Pinedo HM, Lankelma J, Schuurhuis GJ. Cervantes A, et al. Among authors: pinedo hm. Cancer Lett. 1988 Aug 15;41(2):169-77. doi: 10.1016/0304-3835(88)90113-9. Cancer Lett. 1988. PMID: 2841019

10

The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.

Mülder HS, Dekker H, Pinedo HM, Lankelma J. Mülder HS, et al. Among authors: pinedo hm. Biochem Pharmacol. 1995 Sep 28;50(7):967-74. doi: 10.1016/0006-2952(95)00221-k. Biochem Pharmacol. 1995. PMID: 7575681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters